Rationale for Study and Design of COMPEL: An Open-Label, Multicenter Study of the Long-Term Efficacy, Safety, and Tolerability of Onabotulinumtoxin A for Headache Prophylaxis in Adults with Chronic Migraine

P21

  • Blumenfeld, A. M.
  • Aurora, S. K.
  • Laranjo, K.
  • Varon, S. F.
  • Papapetropoulos, S.

  • 1The Neurology Center, Encinitas, CA, USA; 2Swedish Neuroscience Institute, Seattle, WA, USA; 3Allergan, Inc., Irvine, CA, USA; 4University of Miami, Miller School of Medicine, Miami, FL, USA.

Headache 52(5):p 881, May 2012.
Copyright © 2012 Blackwell Publishing Ltd.
View full text|Download PDF